Loss of the oncogenic phosphatase PRL-3 promotes a TNF-R1 feedback loop that mediates triple-negative breast cancer

H H Gari1, G D DeGala1, M S Lucia1

  • 1Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Oncogenesis
|August 16, 2016
PubMed

Insights

Discovering a new sequential cancer therapy: Knocking down PRL-3 in triple-negative breast cancer (TNBC) cells induces senescence then apoptosis via a TNF-R1 feedback loop, offering a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Cancer therapies often target tumor cell senescence and apoptosis.
  • Senescence and apoptosis are typically considered parallel, not sequential, processes.
  • The role of PRL-3 in triple-negative breast cancer (TNBC) and its regulation by NF-κB are key areas of investigation.

Purpose of the Study:

  • To investigate the role of PRL-3 in TNBC.
  • To elucidate the sequential relationship between senescence and apoptosis in TNBC.
  • To explore the mechanism of PRL-3 knockdown-induced cell death.

Main Methods:

  • Utilized knockdown of PRL-3 in TNBC cells.
  • Analyzed cell cycle arrest, cytokine response (TNFα), and cell death pathways.
  • Investigated the involvement of NF-κB and TNF-R1 signaling pathways.

Main Results:

  • PRL-3 knockdown in TNBC cells triggers an autocrine TNF-R1 feedback loop.
  • This leads to sequential TNBC cell senescence followed by apoptosis.
  • TNF-R1 signaling dynamically shifts from NF-κB-mediated senescence to caspase-8-mediated apoptosis.

Conclusions:

  • PRL-3 knockdown represents a novel strategy to modify the TNF-R1 pathway's survival-death balance.
  • Senescent TNBC cells can be sequentially sensitized to undergo apoptosis.
  • This study reveals a novel mechanism for inducing sequential cell death in cancer therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K